Recent News for PSNL - Personalis, Inc.

Date Title
Aug 3 Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy Platform
Jul 30 Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Jul 27 Personalis: Buy This Disruptor In Precision Medicine And Machine Learning
Jul 23 Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020
Jul 16 Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 16 Personalis Further Expands Leadership Team With Appointment of Leslie Grab, VP of Intellectual Property and John Lyle, VP of Assay Research and Development
Jul 10 Personalis, Inc. (PSNL) Shares March Higher, Can It Continue?
Jun 24 Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP
Jun 22 Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting
Jun 18 Personalis to Participate in European Association for Cancer Research (EACR) 2020 Virtual Congress
Jun 16 Personalis to Present at the Precision Breast Cancer Summit
Jun 16 Personalis Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 14 4 Biotech Stocks That Are Seeing Big Buys in June
Jun 10 Personalis partners with Berry Genomics
Jun 10 CORRECTION – SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Personalis, Inc. - PSNL
Jun 10 Personalis Announces a Partnership with Berry Genomics for China Expansion
Jun 10 Hedge Funds Never Been Less Bullish On Personalis, Inc. (PSNL)
Jun 2 Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics
Jun 1 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Personalis, Inc. - PSNL
Jun 1 PSNL Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Personalis, Inc. and Encourages Investors to Contact the Firm
May 29 Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting
May 28 PERSONALIS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Personalis, Inc. To Contact The Firm
May 28 Personalis Shareholders Who Have Suffered Losses Greater Than $50K Encouraged To Contact Kehoe Law Firm, P.C.
May 10 Personalis, Inc. (PSNL) Q1 2020 Earnings Call Transcript
May 9 Personalis, Inc. (PSNL) CEO John West on Q1 2020 Results - Earnings Call Transcript
Back to the Main PSNL Page...